Helsinki Innovation Services is hiring a Business Development Director Digital Precision Cancer Medicine This opportunity is for a dynamic, brave and independent commercialisation enthusiast eager to work with top scientists …
Commissioner Carlos Moedas announced iCAN Executive Officer Tomi Mäkelä is selected to the Mission Board for Cancer. Cancer was selected earlier this year as one of the five European missions …
An exciting job opportunity as Communication Manager for the iCAN flagship – apply now! The iCAN Digital Precision Cancer Medicine cluster is one of Finland’s six research flagships. iCAN integrates …
The kick-off May 29 @TerkkoHealthHub attracted a full house with a great mix of scientists, physicians, innovators, and patient organizations. Following a welcome by Flagship Executive Officer Tomi Mäkelä and …
The challenge of our time
Cancer is a growing threat to our global health. The scientific community and society at large are investing heavily to improve prevention, detection, survival, and quality of life of cancer patients. Precision Cancer Medicine represents a highly promising approach to tackle this global challenge, but there are still a number of bottlenecks.
Combining precision cancer medicine and digital health.
Our approach is based on integrating molecular data with digital health data in new and meaningful ways. Sounds quite straight forward, right? But rest assured, it is a highly challenging task. The good news is that Finland has globally unique assets for actually making this happen.
Empowering patients in cancer care and research
iCAN is an innovative multidisciplinary initiative
that brings together some of the world’s leading actors in cancer genomics,
translational and clinical cancer research, digital health, information technology,
machine learning and business to solve one of the most pressing challenges of our time – cancer.
This unique ecosystem will be based on two national cancer research Centers of Excellence
at the University of Helsinki and the first Nordic Comprehensive Cancer Center at Helsinki University Hospital HUS with an aim to synergize with the national cancer center FICAN and its regional node FICAN South.